PSYCHOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE
Clinical trials for PSYCHOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new PSYCHOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for PSYCHOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to tame terrifying hallucinations in Alzheimer's patients
Disease control Recruiting nowThis study is testing whether a drug called KarXT can help prevent the return of distressing psychosis symptoms—like hallucinations and delusions—in people with Alzheimer's disease. It will involve about 410 participants aged 55-90 who have these symptoms. Over 38 weeks, research…
Matched conditions: PSYCHOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug aims to quiet the distressing voices and false beliefs of Alzheimer's psychosis
Symptom relief Recruiting nowThis study is testing whether an investigational drug called ML-007C-MA can safely reduce hallucinations and delusions in people with Alzheimer's disease. It will involve about 300 participants, aged 55 to 90, who experience these specific symptoms. The drug will be compared agai…
Matched conditions: PSYCHOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: MapLight Therapeutics • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
New hope for calming Alzheimer's hallucinations
Symptom relief Recruiting nowThis study is testing whether an investigational drug called ITI-1284 can help reduce distressing psychosis symptoms—like hallucinations and paranoid thoughts—in people with Alzheimer's disease. About 370 participants will be randomly assigned to receive either the study drug or …
Matched conditions: PSYCHOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Year-Long safety check for promising Alzheimer's psychosis drug
Symptom relief Recruiting nowThis study follows people with Alzheimer's disease who experience psychosis (like hallucinations or delusions) to see how safe a medication called KarXT is when taken for a full year. It's for 800 people who have already completed one of three earlier KarXT studies. The main goal…
Matched conditions: PSYCHOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Karuna Therapeutics • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC